If microbial ecosystem therapy can change your life, what's the problem?

BioEssays

Volumn 35, Issue 6, 2013, Pages 508-512

  Ettinger, Grace ^a   Burton, Jeremy P ^a   Reid, Gregor ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Fecal; Microbial; Probiotics; Regulatory; Stool; Substitute; Transplantation

Indexed keywords

NYYP 901; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG; VANCOMYCIN; YOGHURT;

ADIPOGENESIS; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CHEMOSTAT; CLOSTRIDIUM DIFFICILE INFECTION; COLON CANCER; COLONOSCOPY; COPROPHAGY; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DONOR; DOWN REGULATION; ECZEMA; ENTERITIS; FECAL MICROBIAL TRANSPLANTATION; FECES; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; IRRITABLE COLON; LACTOBACILLUS AMYLOVORUS; LACTOBACILLUS CASEI; LACTOBACILLUS FERMENTUM; LACTOBACILLUS PLANTARUM; LACTOBACILLUS SALIVARIUS; LONG TERM CARE; MEDICAL PRACTICE; MORBIDITY; MORTALITY; MULTIPLE SCLEROSIS; NASOGASTRIC TUBE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PERITONITIS; PHYSICIAN; PRACTICE GUIDELINE; SIGNAL TRANSDUCTION; THERAPY EFFECT; TRANSPLANTATION;

ADMINISTRATION, RECTAL; ANIMALS; DRUG RESISTANCE, BACTERIAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; HUMANS; METAGENOME; OWNERSHIP; PROBIOTICS;

CLOSTRIDIUM DIFFICILE;

EID: 84877920956     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201300015     Document Type: Article

References (42)

1. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, et al. 2013. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368: 407-15.
2. Petrof EO, Gloor GB, Vanner SJ, Weese SJ, et al. 2013. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut. Microbiome 1: 3.
3. Lewin RA. 2001. More on Merde. Perspect Biol Med 44: 594-607.
4. Allen-Vercoe E, Reid G, Viner N, Gloor GB, et al. 2012. A Canadian working group report on fecal microbial therapy: microbial ecosystems therapeutics. Can J Gastroenterol 26: 457-62.
5. Eiseman B, Silen W, Bascom GS, Kauvar AJ. 1958. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44: 854-9.
6. Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A. 2012. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 107: 761-7.
7. Brandt LJ, Aroniadis OC, Mellow M, Kanatzar A, et al. 2012. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol 107: 1079-87.
8. Mattila E, Uusitalo-Seppälä R, Wuorela M, Lehtola L, et al. 2012. Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology 142: 490-6.
9. Bakken JS, Borody T, Brandt LJ, Brill JV, et al. 2011. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 9: 1044-9.
10. Kelly CP. 2013. Fecal microbiota transplantation - an old therapy comes of age. N Engl J Med 368: 474-5.
11. Ursell LK, Clemente JC, Rideout JR, Gevers D, et al. 2012. The interpersonal and intrapersonal diversity of human-associated microbiota in key body sites. J Allergy Clin Immunol 129: 1204-8.
12. Yatsunenko T, Rey FE, Manary MJ, Trehan I, et al. 2012. Human gut microbiome viewed across age and geography. Nature 486: 222-7.
13. Petrof EO, Claud EC, Gloor GB, Allen-Vercoe E. 2013. Microbial ecosystems therapeutics: a new paradigm in medicine? Benef Microbes 4: 53-65.
14. Huse SM, Ye Y, Zhou Y, Fodor AA. 2012. A core human microbiome as viewed through 16S rRNA sequence clusters. PLoS ONE 7: e34242.
15. Jalanka-Tuovinen J, Salonen A, Nikkilä J, Immonen O, et al. 2011. Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms. PLoS ONE 6: e23035.
16. McNulty NP, Yatsunenko T, Hsiao A, Faith JJ, et al. 2011. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med 3: 106ra106.
17. Rohlke F, Stollman N. 2012. Fecal microbiota transplantation in relapsing Clostridium difficile infection. Therap Adv Gastroenterol 5: 403-20.
18. Alander M, Satokari R, Korpela R, Saxelin M, et al. 1999. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol 65: 351-4.
19. Sofi AA, Silverman AL, Khuder S, Garborg K, et al. 2013. Relationship of symptom duration and fecal bacteriotherapy in Clostridium difficile infection-pooled data analysis and a systematic review. Scand J Gastroenterol 48: 266-73.
20. Hawkins AK, O'Doherty KC. 2011. " Who owns your poop?": insights regarding the intersection of human microbiome research and the ELSI aspects of biobanking and related studies. BMC Med Genomics 4: 72.
21. Guillemard E, Tanguy J, Flavigny A, de la Motte S, et al. 2010. Effects of consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 on common respiratory and gastrointestinal infections in shift workers in a randomized controlled trial. J Am Coll Nutr 29: 455-68.
22. Naito S, Koga H, Yamaguchi A, Fujimoto N, et al. 2008. Prevention of recurrence with epirubicin and Lactobacillus casei after transurethral resection of bladder cancer. J Urol 179: 485-90.
23. Wickens K, Black P, Stanley TV, Mitchell E, et al. 2012. A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy 42: 1071-9.
24. Wall R, Marques TM, O'Sullivan O, Ross RP, et al. 2012. Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota. Am J Clin Nutr 95: 1278-87.
25. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022-3.
26. Abdallah Ismail N, Ragab SH, Abd Elbaky A, Shoeib AR, et al. 2011. Frequency of Firmicutes and Bacteroidetes in gut microbiota in obese and normal weight Egyptian children and adults. Arch Med Sci 7: 501-7.
27. Ferrer M, Ruiz A, Lanza F, Haange SB, et al. 2013. Microbiota from the distal guts of lean and obese adolescents exhibit partial functional redundancy besides clear differences in community structure. Environ Microbiol 15: 211-26.
28. Murphy EF, Cotter PD, Hogan A, O'Sullivan O, et al. 2013. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut 62: 220-6.
29. Muccioli GG, Naslain D, Bäckhed F, Reigstad CS, et al. 2010. The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol 6: 392.
30. Chang BJ, Park SU, Jang YS, Ko SH, et al. 2011. Effect of functional yogurt NY-YP901 in improving the trait of metabolic syndrome. Eur J Clin Nutr 65: 1250-5.
31. Omar JM, Chan YM, Jones ML, Prakash S, et al. 2013. Lactobacillus fermentum and Lactobacillus amylovorus as probiotics alter body adiposity and gut microflora in healthy persons. J Funct Foods 5: 116-23.
32. Ramchandran L, Shah NP. 2011. Yogurt can beneficially affect blood contributors of cardiovascular health status in hypertensive rats. J Food Sci 76: H131-6.
33. Collins SM, Surette M, Bercik P. 2012. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 10: 735-42.
34. Clayton TA. 2012. Metabolic differences underlying two distinct rat urinary phenotypes, a suggested role for gut microbial metabolism of phenylalanine and a possible connection to autism. FEBS Lett 586: 956-61.
35. Borody TJ, Leis S, Campbell J, Torres M, et al. 2011. Fecal microbiota transplantion (FMT) in multiple sclerosis (MS). American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course, Washington DC, October 28-November 2, abstract.
36. Markle JG, Frank DN, Mortin-Toth S, Robertson CE, et al. 2013. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339: 1084-8.
37. Kumar M, Nagpal R, Kumar R, Hemalatha R, et al. 2012. Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. Exp Diab Res 2012: 902917.
38. Fuentes MC, Lajo T, Carrion JM, Cune J. 2012. Cholesterol-lowering efficacy of Lactobacillus plantarum CECT 7527, 7528 and 7529 in hypercholesterolemic adults. Brit J Nutr 28: 1-7.
39. Lam V, Su J, Koprowski S, Hsu A, et al. 2012. Intestinal microbiota determine severity of myocardial infarction in rats. FASEB J 26: 1727-35.
40. Kumar M, Nagpal R, Verma V, Kumar A, et al. 2013. Probiotic metabolites as epigenetic targets in the prevention of colon cancer. Nutr Rev 71: 23-4.
41. Rautava S, Kainonen E, Salminen S, Isolauri E. 2012. Maternal probiotic supplementation during pregnancy and breast-feeding reducing the risk of eczema in the infant. J. Allergy Clin Immunol 130: 1355-60.
42. le Roy T, Llopis M, Lepage P, Bruneau A, et al. 2013. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut, in press, DOI: 10.1136/gutjnl-2012-303816